NDC 50090-7357-00 - Bisoprolol Fumarate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7357
- Requested NDC
- 50090-7357-00
- Package NDCs from labels
- 50090-7357-0, 50090-7357-2, 50090-7357-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bisoprolol Fumarate and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2026-03-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7357-0 | Bisoprolol Fumarate and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 6 | |
| 50090-7357-2 | Bisoprolol Fumarate and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7357 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, 2 package rows | 20241023_9271a2d7-be94-4e38-9f71-41e8d55e10bc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7357-0 | EA - Each | 50090-7357 | 21da657a-4571-48f4-a7f7-18a0b4e56ab3 | 1 | 2024-11-05 |
| 50090-7357-2 | EA - Each | 50090-7357 | bd5f6002-c0c5-46c2-bb49-379fcb7379e0 | 1 | 2024-11-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Essential Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 2132dc18-85ee-4449-86d2-d9f698f286c6 | 2024-07-31 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b78ad43f-f132-4f03-8c85-2cf9b3ab555b | 2024-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Proceuticals Private Label by TiZO tinted foaming mineral sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, Ltd | 1e78109f-4d2e-2705-e063-6294a90a5ad3 | 2024-07-30 | Warnings | 15FIX9V2JP |
| Replenix Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 37d1f454-3bc9-4ce5-863c-0d4f6fa18fb4 | 2024-07-29 | Warnings | 15FIX9V2JP |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1e02787f-ccb5-abc2-e063-6294a90af7c3 | 2024-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4af326db-bf2d-5310-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7cc69c16-0dcc-874d-e053-2991aa0a9919 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | af74c331-7402-408c-e053-2a95a90a1043 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b2e8b3bb-0ab5-ffd7-e053-2995a90aa2b6 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b4c9abf7-a2c6-7042-e053-2a95a90a7653 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCarePharmaceuticals, Inc. | 4fbf31a1-037b-31a2-e054-00144ff88e88 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Derma E Sun Defense Face SPF 30 | ZINC OXIDE TITANIUM DIOXIDE | derma e | d90b8f81-de7a-4022-800a-90f063e94180 | 2024-07-17 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7c214ebf-e0ed-6538-e053-2991aa0a8079 | 2024-07-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| PROCEUTICALS PRIVATE LABEL by TiZO mineral lip sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 1d611494-648b-6e5f-e063-6294a90a4500 | 2024-07-16 | Warnings | 15FIX9V2JP |
| SkinCeuticals Physical Fusion UV Defense Broad Spectrum SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | L'Oreal USA Products Inc | 8df98d97-a5d2-4d52-8bd2-130a13501d60 | 2024-07-16 | Warnings | 15FIX9V2JP |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4925a3ad-63bd-108a-e054-00144ff8d46c | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Derma E Sun Defense SPF 30 | ZINC OXIDE AND TITANIUM DIOXIDE | derma e | 395b73a4-dae7-49da-9dab-ab622117c8c0 | 2024-07-12 | Warnings | 15FIX9V2JP |
| PROCEUTICALS PRIVATE LABEL by TiZO non-tinted mineral sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 1ce8c1da-565d-5487-e063-6294a90a1bde | 2024-07-10 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 53fe1730-a803-26b2-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d57188d2-c3af-4879-bf17-f37eaf733aca | 2024-07-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.